
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy
Zaoqu Liu, Zhaokai Zhou, Qin Dang, et al.
Theranostics (2022) Vol. 12, Iss. 14, pp. 6273-6290
Open Access | Times Cited: 86
Zaoqu Liu, Zhaokai Zhou, Qin Dang, et al.
Theranostics (2022) Vol. 12, Iss. 14, pp. 6273-6290
Open Access | Times Cited: 86
Showing 26-50 of 86 citing articles:
Intrinsic tumor-targeted murine Ferritin nanocage co-delivers GPX4 and FSP1 inhibitors for synergistic ferroptosis-immunotherapy
Jin-mei Cheng, Qilin Yu, Jiaxin Li, et al.
Nano Today (2024) Vol. 58, pp. 102411-102411
Closed Access | Times Cited: 4
Jin-mei Cheng, Qilin Yu, Jiaxin Li, et al.
Nano Today (2024) Vol. 58, pp. 102411-102411
Closed Access | Times Cited: 4
A mathematical model to the melanoma dynamics involving CAR T-cells
Gilberto César Lopes Rodrigues, Jairo G. Silva, Mostafa Adimy, et al.
Computational and Applied Mathematics (2025) Vol. 44, Iss. 1
Closed Access
Gilberto César Lopes Rodrigues, Jairo G. Silva, Mostafa Adimy, et al.
Computational and Applied Mathematics (2025) Vol. 44, Iss. 1
Closed Access
ROR1 CAR-T cells and ferroptosis inducers orchestrate tumor ferroptosis via PC-PUFA2
Dan Li, Wenjie Zhang, Ruiheng Wang, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Dan Li, Wenjie Zhang, Ruiheng Wang, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Challenges and overcoming strategies in CAR-T cell therapy for pediatric neuroblastoma
Pei-Ting Ying, Yongmin Tang
World Journal of Pediatrics (2025)
Closed Access
Pei-Ting Ying, Yongmin Tang
World Journal of Pediatrics (2025)
Closed Access
Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy
Anna De Lucia, L. Mazzotti, Anna Gaimari, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Anna De Lucia, L. Mazzotti, Anna Gaimari, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
CAR-T therapy for endocrine neoplasms: novel targets and combination of therapies
Fang Wang, Ruiqi Zhang, Zhaokai Zhou, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Fang Wang, Ruiqi Zhang, Zhaokai Zhou, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Use of a universal targeting CAR T cell to simultaneously kill cancer cells and cancer-associated fibroblasts
Bo Huang, Suilan Zheng, Kasireddy Sudarshan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Bo Huang, Suilan Zheng, Kasireddy Sudarshan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Role of liposomes in chemoimmunotherapy of Breast cancer
Fatemeh Attarian, Ghazaleh Hatamian, Shamim Nosrati, et al.
Journal of drug targeting (2025), pp. 1-43
Closed Access
Fatemeh Attarian, Ghazaleh Hatamian, Shamim Nosrati, et al.
Journal of drug targeting (2025), pp. 1-43
Closed Access
Clinical evidence of immunogenicity of CAR-T cell therapies and its implication in the clinical development of CAR-T drug products
Hammodah R. Alfar, Cecil Chen, Eric J. Lachacz, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Hammodah R. Alfar, Cecil Chen, Eric J. Lachacz, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Tumor microenvironment as a novel therapeutic target for lymphoid leukemias
Seyed-Reza Mousavi, S. Nouri, Arezoo Sadeghipour, et al.
Annals of Hematology (2025)
Open Access
Seyed-Reza Mousavi, S. Nouri, Arezoo Sadeghipour, et al.
Annals of Hematology (2025)
Open Access
Enhanced efficacy of dual chimeric antigen receptor-T cells targeting programmed death-ligand 1 and cancer-associated fibroblasts in colorectal cancer in vitro
Yang Gao, Chunxiong Luo, Hua Yang, et al.
CytoJournal (2025) Vol. 22, pp. 29-29
Open Access
Yang Gao, Chunxiong Luo, Hua Yang, et al.
CytoJournal (2025) Vol. 22, pp. 29-29
Open Access
Biomedical Imaging: Scope for Future Studies and Applications
Sukumaran Anil, Biba Vikas, Nebu George Thomas, et al.
Biological and medical physics series (2025), pp. 319-338
Closed Access
Sukumaran Anil, Biba Vikas, Nebu George Thomas, et al.
Biological and medical physics series (2025), pp. 319-338
Closed Access
CAR-T cell therapy for patients with extramedullary multiple myeloma:opportunities and challenges
Yin Wang, Xiaoli Hu, Juan Du, et al.
European Journal of Cancer (2025) Vol. 220, pp. 115374-115374
Closed Access
Yin Wang, Xiaoli Hu, Juan Du, et al.
European Journal of Cancer (2025) Vol. 220, pp. 115374-115374
Closed Access
Advancements and challenges in CAR T cell therapy for pediatric brain tumors: A review
Yasmina Gaoual, Adam Mahyaoui, L Yachi, et al.
Journal of Oncology Pharmacy Practice (2025)
Closed Access
Yasmina Gaoual, Adam Mahyaoui, L Yachi, et al.
Journal of Oncology Pharmacy Practice (2025)
Closed Access
CAR-T and Nanotechnology: A Comparative Perspective on Autoimmune Disease and Cancer
A.J. Pavithra, Chinnasamy Ragavendran
Advances in Biomarker Sciences and Technology (2025)
Open Access
A.J. Pavithra, Chinnasamy Ragavendran
Advances in Biomarker Sciences and Technology (2025)
Open Access
Research status and frontiers in liver cancer immunotherapy: a bibliometric perspective on highly cited literature
Pan Su, Yongkai Han, Jindong Yi, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Pan Su, Yongkai Han, Jindong Yi, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
SOHO State of the Art Updates and Next Questions | CD7 CAR-T Therapy for Treating CD7-Positive Hematological Malignancies: Clinical Advances and Future Directions
Peihua Lu, Jing Long
Clinical Lymphoma Myeloma & Leukemia (2025)
Closed Access
Peihua Lu, Jing Long
Clinical Lymphoma Myeloma & Leukemia (2025)
Closed Access
Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy
Saber Imani, Reyhaneh Farghadani, Ghazaal Roozitalab, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Saber Imani, Reyhaneh Farghadani, Ghazaal Roozitalab, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Crosstalk between the tumor immune microenvironment and metabolic reprogramming in pancreatic cancer: new frontiers in immunotherapy
Jingjing Shi, Xiaoyan Cui, Junlin Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Jingjing Shi, Xiaoyan Cui, Junlin Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Micellar formulation provides potent and tolerable TLR7 agonist treatment for anti-cancer immunotherapy
Esben Christensen, Camilla Stavnsbjerg, Rasmus Münter, et al.
The Journal of Immunology (2025)
Open Access
Esben Christensen, Camilla Stavnsbjerg, Rasmus Münter, et al.
The Journal of Immunology (2025)
Open Access
Case Report: Combined PD-1 and tyrosine kinase blockade stabilizes refractory pancreatic cancer guided by the spatial structure of tumor immune microenvironment
Heqi Yang, Yuhang Ma, Chenyan Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Heqi Yang, Yuhang Ma, Chenyan Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The evolving landscape of oncolytic virus immunotherapy: combinatorial strategies and novel engineering approaches
Mujibullah Sheikh, Arshiya Saiyyad, Aimé Aliunui, et al.
Medical Oncology (2025) Vol. 42, Iss. 6
Closed Access
Mujibullah Sheikh, Arshiya Saiyyad, Aimé Aliunui, et al.
Medical Oncology (2025) Vol. 42, Iss. 6
Closed Access
Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance
Assunta Melaccio, Antonia Reale, Ilaria Saltarella, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6491-6491
Open Access | Times Cited: 16
Assunta Melaccio, Antonia Reale, Ilaria Saltarella, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6491-6491
Open Access | Times Cited: 16
Synergist for antitumor therapy: Astragalus polysaccharides acting on immune microenvironment
Xu Qian, Wen Cheng, Jinrui Wei, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Xu Qian, Wen Cheng, Jinrui Wei, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Living Cell‐Derived Intelligent Nanobots for Precision Oncotherapy
Liqiang Zhou, Kun Li, Yingying Liu, et al.
Advanced Functional Materials (2023) Vol. 34, Iss. 10
Closed Access | Times Cited: 10
Liqiang Zhou, Kun Li, Yingying Liu, et al.
Advanced Functional Materials (2023) Vol. 34, Iss. 10
Closed Access | Times Cited: 10